GTBP

GT BIOPHARMA INC

GTBP·36254L308·US·Common Stock·Healthcare - Biotechnology-13D/G

GTBP (GT BIOPHARMA INC) is held by 23 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($184,436), GEODE CAPITAL MANAGEMENT, LLC ($130,648), VANGUARD FIDUCIARY TRUST CO ($110,710). Net institutional sentiment: Mixed.

23
Holders
(2 Elite)
$608,528
Total Value
57% (23)
Consensus
13 buying - 10 selling
13F: Insider & Congress: Updated regularly
GTBP

Smart Money Verdict

View all
Loading verdict
Held by 23 funds
2 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Jun 2, 2025 · Congress none

ActivistBIBristol Investment Fund, Ltd.2.4%Jun 2, 2025
ActivistFNFive Narrow Lane LP10.0%May 14, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
376,399(-16.7%)$184,4360.0%-38.28%
0
Decreased
266,788(-9.4%)$130,6480.0%-96.10%
0
Unchanged
225,938$110,7100.0%-38.28%
0
New
75,461$36,9530.0%-40.80%
31
New
55,936$27,3920.0%-40.80%
30
New
40,000$19,6000.0%-40.80%
29
Increased
40,012(+100.0%)$19,5940.0%-55.37%
30
Increased
38,500(+83.3%)$18,8570.0%-55.14%
20
Increased
36,379(+19.7%)$17,8150.0%-49.35%
15
Increased
22,573(+36.0%)$11,0540.0%-70.90%
15
New
20,000$10,0000.0%-40.80%
26
Decreased
15,986(-0.3%)$7,8280.0%-93.98%
0
Decreased
8,312(-1.1%)$4,0700.0%-90.49%
0
Increased
7,600(+5931.8%)$4,0000.0%-40.76%
16
Unchanged
4,501$2,2050.0%-38.36%
0
Unchanged
3,000$1,4690.0%-64.19%
0
New
1,441$7060.0%-40.80%
17
New
1,500$6450.0%-40.80%
17
New
1,000$4900.0%-40.80%
17
New
107,140$520.0%-40.80%
15

Showing 1-20 of 27

1 / 2
GTBPGTBPGT BIOPHARMA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used